Updated on 2024/10/07

Information

 

写真a

 
NAKANO YASUHIRO
 
Organization
Kyushu University Hospital Angiocardiology Assistant Professor
Kyushu University Hospital Angiocardiology（Concurrent）
School of Medicine Department of Medicine（Concurrent）
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926425360
Profile
General Cardiology Coronary Intervention Peripheral Artery Intervention Cardiac CT Clinical Research
External link

Degree

  • MD, PhD

Research Interests・Research Keywords

  • Research theme：Coronary intervention Cardiac CT Coronary artery calcification

    Keyword：Coronary intervention, Cardiac CT, Coronary artery calcification

    Research period： 2023.6

Papers

  • Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study.

    Oba Y, Kabutoya T, Kohro T, Imai Y, Kario K, Sato H, Nochioka K, Nakayama M, Akashi N, Fujita H, Mizuno Y, Kiyosue A, Iwai T, Miyamoto Y, Nakano Y, Ishii M, Nakamura T, Tsujita K, Matoba T, Nagai R; CLIDAS research group.

    Hypertens Res.   2024.9

  • Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on the Severity and the Mortality of Acute Myocardial Infarction in Japan - Analysis From the JROAD-DPC Database.

    Kimura M, Matoba T, Nakano Y, Katsuki S, Sakamoto K, Nishihara M, Nagata T, Tahara Y, Nagao K, Okura H, Ikeda T, Nakai M, Tsutsui H.

    Circ Rep.   2024.5

  • Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan.

    Nakano Y, Matoba T, Yamamoto M, Katsuki S, Koga Y, Mukai Y, Inoue S, Suematsu N, Higo T, Takemoto M, Miyata K, Usui M, Kadokami T, Tashiro H, Morishige K, Hironaga K, Tsutsui H; for the QcVIC Investigators

    Circ Rep.   2023.6

  • Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis.

    Akiyama Y, Katsuki S, Matoba T, Nakano Y, Takase S, Nakashiro S, Yamamoto M, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H.

    Nutrients.   2023.5

  • JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction.

    Hokimoto S, Kaikita K, Yasuda S, Tsujita K, Ishihara M, Matoba T, Matsuzawa Y, Mitsutake Y, Mitani Y, Murohara T, Noda T, Node K, Noguchi T, Suzuki H, Takahashi J, Tanabe Y, Tanaka A, Tanaka N, Teragawa H, Yasu T, Yoshimura M, Asaumi Y, Godo S, Ikenaga H, Imanaka T, Ishibashi K, Ishii M, Ishihara T, Matsuura Y, Miura H, Nakano Y, Ogawa T, Shiroto T, Soejima H, Takagi R, Tanaka A, Tanaka A, Taruya A, Tsuda E, Wakabayashi K, Yokoi K, Minamino T, Nakagawa Y, Sueda S, Shimokawa H, Ogawa H

    Circ J.   2023.5

  • Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition System.

    Yusuke Oba, Tomoyuki Kabutoya, Takahide Kohro, Yasushi Imai, Kazuomi Kario, Hisahiko Sato, Kotaro Nochioka, Masaharu Nakayama, Hideo Fujita, Yoshiko Mizuno, Arihiro Kiyosue, Takamasa Iwai, Yoshihiro Miyamoto, Yasuhiro Nakano, Taishi Nakamura, Kenichi Tsujita, Tetsuya Matoba, Ryozo Nagai,

    Circ J.   2023.1

  • Association between serum oxysterols and coronary plaque regression during lipid-lowering therapy with statin and ezetimibe: Insights from the CuVIC trial.

    Nakano Y, Yamamoto M, Matoba T, Katsuki S, Nakashiro S, Takase S, Akiyama Y, Nagata T, Mukai Y, Inoue S, Oi K, Higo T, Takemoto M, Suematsu N, Eshima K, Miyata K, Usui M, Sadamatsu K, Kadokami T, Hironaga K, Ichi I, Todaka K, Kishimoto J, Tsutsui H; for the QcVIC Investigators.

    J Atheroscler Thromb.   2022.11

  • Histologic Diagnosis of Coronary Amyloidosis Using Percutaneous Transluminal Directional Atherectomy.

    Yoshida D, Hashimoto T, Katsuki M, Ishikita A, Ishikawa Y, Fujino T, Shinohara K, Matsushima S, Kinugawa S, Nakano Y, Katsuki S, Matoba T, Hayashidani S, Tsutsui H.

    CJC Open.   2022.10

  • Percutaneous coil embolization and stent implantation for multiple coronary-to-pulmonary artery fistulas with giant coronary aneurysms; a case report.

    Nakano Y, Matoba T, Nagatomo Y, Tsutsui H.

    Eur Heart J Case Rep.   2022.3

  • Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2 nd-Generation Drug-Eluting Stents.

    Akiyama Y, Matoba T, Katsuki S, Takase S, Nakashiro S, Nakano Y, Noma K, Tsutsui H.

    J Atheroscler Thromb.   2022.3

  • PPARγ-targeting Nanomedicine Promotes Cardiac Healing After Acute Myocardial Infarction by Skewing Monocyte/Macrophage Polarization in Preclinical Animal Models.

    Tokutome M, Matoba T, Nakano Y, Okahara A, Fujiwara M, Koga J, Nakano K, Tsutsui H, Egashira K.

    Cardiovasc Res.   2019.1

  • Successful Intravascular Ultrasound-Guided Transradial Coronary Intervention with a 4Fr Guiding Catheter.

    Nakano Y, Sadamatsu K.

    Case Rep Cardiol   2016.9

  • The Effect of Low Frame Rate Fluoroscopy on the X-ray Dose during Coronary Intervention.

    Sadamatsu K, Nakano Y.

    Intern Med.   2016.8

  • Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.

    Nakano Y, Matoba T, Tokutome M, Funamoto D, Katsuki S, Ikeda G, Nagaoka K, Ishikita A, Nakano K, Koga J, Sunagawa K, Egashira K.

    Sci Rep.   2016.6

  • Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.

    Ikeda G, Matoba T, Nakano Y, Nagaoka K, Ishikita A, Nakano K, Funamoto D, Sunagawa K, Egashira K.

    Sci Rep.   2016.2

  • Balloon crushing of a protruding everolimus-eluting stent for isolated coronary stenosis at the side branch ostium.

    Sadamatsu K, Okahara A, Nakano Y, Mine D, Koga Y.

    Int J Cardiol.   2015.11

  • A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.

    Nagaoka K, Matoba T, Mao Y, Nakano Y, Ikeda G, Egusa S, Tokutome M, Nagahama R, Nakano K, Sunagawa K, Egashira K.

    PLoS One.   2015.7

  • Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.

    Katsuki S, Matoba T, Nakashiro S, Sato K, Koga J, Nakano K, Nakano Y, Egusa S, Sunagawa K, Egashira K.

    Circulation.   2014.2

▼display all

Professional Memberships

  • The Japanese Society of Internal Medicine, The Japanese Circulation Society, Japanese Association of Cardiovascular Intervention and Therapeutics

Educational Activities

  • Education for medical students: Bedside teaching for grade 5, Clinical clerkship for grade 6
    Education for medical staff in the university hospital on cardiac catheterization and treatment

Class subject

  • 循環器内科

    2023.4 - 2024.3   Full year